Viewing StudyNCT06305910



Ignite Creation Date: 2024-05-06 @ 8:14 PM
Last Modification Date: 2024-10-26 @ 3:23 PM
Study NCT ID: NCT06305910
Status: RECRUITING
Last Update Posted: 2024-03-12
First Post: 2024-03-05

Brief Title: CD200AR-L and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent HGG and Newly Diagnosed DMGDIPG in Children and Young Adults
Sponsor: OX2 Therapeutics
Organization: OX2 Therapeutics

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-03-15
Start Date Type: ESTIMATED
Primary Completion Date: 2025-09-15
Primary Completion Date Type: ESTIMATED
Completion Date: 2027-01-15
Completion Date Type: ESTIMATED
First Submit Date: 2024-03-05
First Submit QC Date: March 5 2024
Study First Post Date: 2024-03-12
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-03-05
Last Update Post Date: 2024-03-12
Last Update Post Date Type: ACTUAL